X
20
Cipla Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Zidovudine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2008-125 - Rev 00
This Chemical Type CEP, issued on May 02, 2018, remains in force until March 26, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 1059 associated with this CEP further emphasizes